Innovent Biologics Inc
HKEX:1801

Watchlist Manager
Innovent Biologics Inc Logo
Innovent Biologics Inc
HKEX:1801
Watchlist
Price: 35.2 HKD -2.22%
Market Cap: 57.7B HKD
Have any thoughts about
Innovent Biologics Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
Innovent Biologics Inc

Wall Street analysts forecast Innovent Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Innovent Biologics Inc is 57.84 HKD with a low forecast of 37.37 HKD and a high forecast of 71.19 HKD.

Lowest
Price Target
37.37 HKD
6% Upside
Average
Price Target
57.84 HKD
64% Upside
Highest
Price Target
71.19 HKD
102% Upside
Innovent Biologics Inc Competitors:
Price Targets
2315
Biocytogen Pharmaceuticals Beijing Co Ltd
80% Upside
SIGHT
Gensight Biologics SA
40% Upside
SPRY
ARS Pharmaceuticals Inc
165% Upside
ALNY
Alnylam Pharmaceuticals Inc
26% Upside
ABBV
Abbvie Inc
20% Upside
GNS
Genus PLC
59% Upside
6955
Shandong Boan Biotechnology Co Ltd
31% Upside
BCRX
BioCryst Pharmaceuticals Inc
100% Upside

Revenue
Forecast

Revenue Estimate
Innovent Biologics Inc

For the last 6 years the compound annual growth rate for Innovent Biologics Inc's revenue is 164%. The projected CAGR for the next 4 years is 31%.

164%
Past Growth
31%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Innovent Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat

Net Income
Forecast

Net Income Estimate
Innovent Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
24%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Innovent Biologics Inc's stock price target?
Price Target
57.84 HKD

According to Wall Street analysts, the average 1-year price target for Innovent Biologics Inc is 57.84 HKD with a low forecast of 37.37 HKD and a high forecast of 71.19 HKD.

What is Innovent Biologics Inc's Revenue forecast?
Projected CAGR
31%

For the last 6 years the compound annual growth rate for Innovent Biologics Inc's revenue is 164%. The projected CAGR for the next 4 years is 31%.

Back to Top